EVOMMUNE INC (EVMN) Stock Income Statement
USA • New York Stock Exchange • NYSE:EVMN • US30054Y1073
18.48 USD
-0.75 (-3.9%)
At close: Feb 3, 2026
18.48 USD
0 (0%)
After Hours: 2/3/2026, 8:13:14 PM
| 2024 (2024-12-31) | 2023 (2023-12-31) | ||||
|---|---|---|---|---|---|
| Revenue | 7.00M | 5.00M | |||
| Operating Expenses | 77.01M | 42.85M | |||
| Research and Development | 64.24M | 32.00M | |||
| Selling, General, and Administrative Expenses | 12.77M | 10.85M | |||
| Operating Income | -70.01M | -37.85M | |||
| Interest Income/Expense | 3.24M | 3.86M | |||
| Other Income/Expense | -37.00K | -59.00K | |||
| Income Before Taxes | -66.81M | -34.05M | |||
| Net Income | -68.31M | -34.05M | |||
| EBITDA | -68.73M | -36.85M | |||
| Per Share Data | |||||
| EPS Diluted Total Ops | -2.27 | -1.13 | |||
| Statistics | |||||
| Profit Margin | -975.83% | -681.06% | |||
| Operating Profit Margin | -1000.19% | -757.00% | |||
All data in USD